{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-023788","form_type":"8-K","ticker":"DRS","cik":"0001833756","company_name":"Leonardo DRS, Inc.","filed_at":"2024-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.571521+00:00","generated_at":"2026-06-01T21:40:00.376966+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Leonardo DRS stockholders approve ESPP (2M shares) and amended equity plan at annual meeting","bullets":["ESPP authorized up to 2M shares; purchase price 90% of FMV on purchase date; payroll deductions up to 10% of compensation.","Amended 2022 Omnibus Equity Compensation Plan approved; allows various equity awards for employees, directors, consultants.","All 9 director nominees elected with >236M votes each; advisory say-on-pay passed with 250.5M for vs 0.8M against.","Ratification of Ernst & Young as independent auditor for FY2024 approved with 255.2M votes for.","ESPP and amended plan effective May 15, 2024; no material financial terms changed beyond share reserve."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-023788","json":"https://secwatch.observer/filing/0001628280-24-023788.json","markdown":"https://secwatch.observer/filing/0001628280-24-023788.md","text":"https://secwatch.observer/filing/0001628280-24-023788.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/drs-20240515.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T21:40:00.376966+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2753bb5f43221f2f6410db5e6097498dd4615b7b","claim":"Leonardo DRS, Inc. shareholders approved Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan at the 2024-05-15 meeting.","evidence_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","confidence":0.95},{"claim_id":"5fe34aa82860c547160cd94527695171c4e4ea89","claim":"Leonardo DRS, Inc. shareholders approved Approval of the Amendment and Restatement of the Leonardo DRS, Inc. 2022 Omnibus Equity Compensation Plan at the 2024-05-15 meeting.","evidence_excerpt":"Approval of the Amendment and Restatement of the Leonardo DRS, Inc. 2022 Omnibus Equity Compensation Plan 250,467,618 861,989 87,959 3,912,857","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","confidence":0.95},{"claim_id":"7d4d81cb1dc209168270050168a3a1034075eeba","claim":"Leonardo DRS, Inc. shareholders approved Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2024 at the 2024-05-15 meeting.","evidence_excerpt":"Ratification of Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2024 255,204,772 67,207 58,444 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","confidence":0.95},{"claim_id":"b3411a48762a7f152d53f9d1c014443561195a1b","claim":"Leonardo DRS, Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.","evidence_excerpt":"Election of Directors Shares Voted For Shares Voted Against Withheld Broker Non-Votes William J. Lynn III 249,843,624 N/A 1,573,942 3,912,857 Frances F. Townsend 249,969,986 N/A 1,447,580 3,912,857 Gail S. Baker 250,761,350 N/A 656,216 3,912,857 Dr. Louis R. Brothers 250,768,672 N/A 648,894 3,912,857 David W. Carey 249,336,972 N/A 2,080,594 3,912,857 General George W. Casey, Jr. 250,763,399 N/A 654,167 3,912,857 Mary E. Gallagher 250,765,518 N/A 652,048 3,912,857 Kenneth J. Krieg 236,280,607 N/A 15,136,959 3,912,857 Eric Salzman 250,051,465 N/A 1,366,101 3,912,857","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","confidence":0.85},{"claim_id":"cdd6949fb1262b6f2988d0b70a6cab6ab8c5a1ef","claim":"Leonardo DRS, Inc. shareholders approved Advisory Resolution Regarding Compensation of the Company’s NEOs at the 2024-05-15 meeting.","evidence_excerpt":"Advisory Resolution Regarding Compensation of the Company’s NEOs 250,541,067 755,296 121,203 3,912,857","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001108524-26-000131","ticker":"CRM","company_name":"Salesforce, Inc.","filed_at":"2026-06-01T20:43:09+00:00","headline":"Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected","event_type":"other_material","sec_items":["5.07","5.02","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001108524-26-000131","json":"https://secwatch.observer/filing/0001108524-26-000131.json","markdown":"https://secwatch.observer/filing/0001108524-26-000131.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1108524/000110852426000131/0001108524-26-000131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1108524/000110852426000131/crm-20260528.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","comparable_excerpt":"Advisory vote to approve the fiscal 2026 compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 493,864,228 117,716,717 668,510 102,463,325","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1108524/000110852426000131/0001108524-26-000131-index.htm"}},{"accession":"0000790816-26-000019","ticker":null,"company_name":"BRANDYWINE OPERATING PARTNERSHIP, L.P.","filed_at":"2026-06-01T20:30:42+00:00","headline":"Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP","event_type":"other_material","sec_items":["1.01","2.03","5.02","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000790816-26-000019","json":"https://secwatch.observer/filing/0000790816-26-000019.json","markdown":"https://secwatch.observer/filing/0000790816-26-000019.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/790816/000079081626000019/bdn-20260528.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","comparable_excerpt":"PROPOSAL 2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for calendar year 2026. Votes For Votes Against Abstentions 134,853,955 7,100,190 646,621","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1060386/000079081626000019/0000790816-26-000019-index.htm"}},{"accession":"0000908937-26-000015","ticker":"SIRI","company_name":"SIRIUS XM HOLDINGS INC.","filed_at":"2026-06-01T20:28:55+00:00","headline":"Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000908937-26-000015","json":"https://secwatch.observer/filing/0000908937-26-000015.json","markdown":"https://secwatch.observer/filing/0000908937-26-000015.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/0000908937-26-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/siri-20260528.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","comparable_excerpt":"Item 2 – Advisory Vote on Named Executive Officer Compensation The holders of our common stock approved, on a non-binding advisory basis, the compensation paid to our named executive officers. Votes Cast For Votes Cast Against Abstentions Broker Non-Votes 228,280,853 4,764,836 1,349,137 51,448,019","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/908937/000090893726000015/0000908937-26-000015-index.htm"}},{"accession":"0001628280-26-039518","ticker":"ESPR","company_name":"Esperion Therapeutics, Inc.","filed_at":"2026-06-01T20:22:15+00:00","headline":"Esperion shareholders approve 7M-share increase to 2022 equity incentive plan","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039518","json":"https://secwatch.observer/filing/0001628280-26-039518.json","markdown":"https://secwatch.observer/filing/0001628280-26-039518.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039518/0001628280-26-039518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039518/espr-20260528.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","comparable_excerpt":"The Company’s stockholders approved Proposal 3. The votes cast at the Annual Meeting were as follows: For Against Abstain Broker Non-Votes 167,083,447 8,765,273 1,360,136 —","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039518/0001628280-26-039518-index.htm"}},{"accession":"0000092380-24-000094","ticker":"LUV","company_name":"SOUTHWEST AIRLINES CO","filed_at":"2024-05-20T23:59:59+00:00","headline":"Southwest shareholders approve amended equity plan with 4.75M share increase; all directors elected","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000092380-24-000094","json":"https://secwatch.observer/filing/0000092380-24-000094.json","markdown":"https://secwatch.observer/filing/0000092380-24-000094.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/92380/000009238024000094/0000092380-24-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/92380/000009238024000094/luv-20240515.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","comparable_excerpt":"3. Proposal 3 – Approval of the Southwest Airlines Co. Amended and Restated 2007 Equity Incentive Plan: VOTES FOR VOTES AGAINST ABSTENTIONS BROKER NON-VOTES 408,346,613 28,870,401 1,635,532 90,613,942","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/92380/000009238024000094/0000092380-24-000094-index.htm"}},{"accession":"0001193125-24-141703","ticker":null,"company_name":"Regulus Therapeutics Inc.","filed_at":"2024-05-17T23:59:59+00:00","headline":"Regulus shareholders approve 2019 Equity Plan amendment adding 9.5M shares","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-141703","json":"https://secwatch.observer/filing/0001193125-24-141703.json","markdown":"https://secwatch.observer/filing/0001193125-24-141703.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505512/000119312524141703/0001193125-24-141703-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505512/000119312524141703/d829869d8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","comparable_excerpt":"Proposal 5. The Company’s stockholders approved the Amended 2019 Plan which, among other things, increased the number of shares of our common stock authorized for issuance under the 2019 Plan by 9,500,000 shares and modified the calculation of the annual automatic share reserve increase to take into account shares of common stock issuable upon conversion or exercise of convertible preferred stock and prefunded warrants. Votes For Votes Against Abstentions Broker Non-Votes 32,563,555 5,916,084 29,301 3,688,130","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1505512/000119312524141703/0001193125-24-141703-index.htm"}},{"accession":"0001628280-24-024025","ticker":"OSUR","company_name":"ORASURE TECHNOLOGIES INC","filed_at":"2024-05-17T23:59:59+00:00","headline":"OraSure shareholders approve 3M share increase in stock plan, charter amendment limiting officer liability","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-024025","json":"https://secwatch.observer/filing/0001628280-24-024025.json","markdown":"https://secwatch.observer/filing/0001628280-24-024025.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1116463/000162828024024025/0001628280-24-024025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1116463/000162828024024025/osur-20240514.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","comparable_excerpt":"ITEM 1 . Election of two Class III Directors for Terms Ending in 2027. NAME Votes For Votes Against Abstentions Broker Non-Votes Nancy J. Gagliano, M.D. 57,243,711 4,832,639 46,575 5,007,157 Lelio Marmora 57,332,773 4,732,865 57,287 5,007,157","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1116463/000162828024024025/0001628280-24-024025-index.htm"}},{"accession":"0001079973-24-000772","ticker":null,"company_name":"Nemaura Medical Inc.","filed_at":"2024-05-17T23:59:59+00:00","headline":"Shareholders approve reverse stock split authorization at ratio of 1:10 to 1:150","event_type":"other_material","sec_items":["5.07","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-000772","json":"https://secwatch.observer/filing/0001079973-24-000772.json","markdown":"https://secwatch.observer/filing/0001079973-24-000772.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1602078/000107997324000772/0001079973-24-000772-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1602078/000107997324000772/nmra_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Approval of the Leonardo DRS, Inc. Employee Stock Purchase Plan 251,319,881 69,247 28,438 3,912,857","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1833756/000162828024023788/0001628280-24-023788-index.htm","comparable_excerpt":"On May 9, 2024, the Shareholders of Nemaura Medical Inc. (the “Company”) approved by written consent to authorize amendments to the Articles of Incorporation of the Company (the “Articles”) to effect a reverse stock split of the common stock, par value $0.001 per share, of the Company (the “Common Stock”) ranging in ratio between 1-for-10 and 1-for-150, with one share of Common Stock being issued for a range of between each 10 and 150 shares of Common Stock issued and outstanding, with such final ratio to be determined by the Board following approval thereof by the shareholders of the Company, with any fractional shares of Common Stock resulting therefrom being rounded up to the nearest whole share of Common Stock (the “Reverse Split”), and to amend the Articles to effect the Reverse Split.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1602078/000107997324000772/0001079973-24-000772-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}